| 10493129 |
Use of fibroblast growth factor 2 |
Xiliang Wang, Chengyu JIANG, Penghui Yang, Xin Liu, Yueqiang Duan +1 more |
2019-12-03 |
| 10463675 |
Aminopyrimidinyl compounds |
Andrew Fensome, Ariamala Gopalsamy, Brian Stephen Gerstenberger, Ivan Viktorovich Efremov, Zhao-Kui Wan +5 more |
2019-11-05 |
| 10426135 |
Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof |
Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente +6 more |
2019-10-01 |
| 10385036 |
Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof |
Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente +6 more |
2019-08-20 |
| 10336748 |
Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof |
Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente +6 more |
2019-07-02 |
| 10308615 |
Heterocyclic compounds as inhibitors of Vanin-1 enzyme |
Agustin Casimiro-Garcia, Jeffrey Scott Condon, Andrew Christopher Flick, Ariamala Gopalsamy, Steven J. Kirincich +4 more |
2019-06-04 |
| 10266513 |
Bruton's tyrosine kinase inhibitors |
John Robert Springer, Balekudru Devadas, Danny James Garland, Margaret L. Grapperhaus, Seungil Han +9 more |
2019-04-23 |
| 10227346 |
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof |
Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente +6 more |
2019-03-12 |
